Guest guest Posted February 2, 2005 Report Share Posted February 2, 2005 " Amy Sasser " <asasser Wed, 2 Feb 2005 07:52:42 -0500 DISCLOSURE of Information on Project 112 DISCLOSURE of Information on Project 112 embedded links & Chart*@ http://deploymentlink.osd.mil/current_issues/shad/final_report/disclose.htm This report is submitted pursuant to section 709(e) of the National Defense Authorization Act for Fiscal Year 2003, Public Law 107-314 and documents completion of Department of Defense activities contemplated by the investigation plan submitted pursuant to sections 709(a) and (b) of the same law. This law called for submission by the Department of Defense (DoD) to Congress and the Secretary of Veterans Affairs (VA) of a comprehensive plan for the review, declassification, and submittal to VA of all DoD information on Project 112 relevant to the provision of VA benefits to Project 112 participants, and then for a six-month progress report and final report upon completion of all activities contemplated by the comprehensive plan. The statute defines Project 112 as the chemical and biological weapons vulnerability testing program conducted by the Deseret Test Center from 1963 to 1969, including the Shipboard Hazard and Defense (SHAD) project. Historical Perspective In 1961, Secretary of Defense Robert McNamara launched a wide-ranging assessment of how the Department of Defense (DoD) was organized and how the armed forces were structured and equipped to secure the nation. Of the approximately 150 sequentially numbered intensive studies undertaken, the 112th addressed chemical and biological warfare capabilities and defense. Project 112 began during the early Cold War era when the United States faced a nuclear threat from both the Soviet Union and China. The Soviet Union was also suspected of having active chemical and biological warfare development programs. The United States considered chemical and biological warfare as an alternative to nuclear war. However, knowledge of nerve agent behavior in the field and operational decontamination in varying climates and terrain was limited. Despite extensive experimentation by the British and Japanese during Word War II, reliable biological agent weaponization had not been achieved. The effects of biological weapons in varying climates and terrain were also largely unexplored. Because DoD's knowledge of chemical and biological warfare agent behavior was so limited, a testing program was begun. The U.S. Army was directed to establish a test center that would be staffed and funded by all the Services and would coordinate a joint test program. The Army established the Deseret Test Center at Fort Douglas, Utah, in June 1962. That location allowed test center personnel to take advantage of facilities and personnel at Dugway Proving Ground, Utah, to support tests, which were expected to be conducted in the Pacific Ocean or on land in Alaska, Hawaii and the then-Panama Canal Zone. From 1962 to 1973, the Deseret Test Center conducted a series of operational chemical and biological warfare tests in support of Project 112. Project SHAD (Shipboard Hazard and Defense) was a subset of that program. Much of the chemical and biological warfare agent behavior information collected then remains valid today. The Deseret Test Center's testing objectives and priorities were established at a series of more-or-less annual joint planning conferences attended by representatives of the Services and Joint and Combatant Commands. The Center's biological testing program was significantly curtailed after President Nixon's November 25, 1969, renunciation of biological weapons and limitation of research to " techniques of immunization and measures of controlling and preventing the spread of disease. " A week earlier, passage and signature of Public Law 91-121 had inserted the then-Department of Health, Education and Welfare into the approval process for all open-air tests involving actual chemical or biological agents. A year later, the Clean Air Act of 1970 formally established guidelines on the release of substances into the air. By mid-1971, the Deseret Test Center's funding had been severely curtailed and it closed in 1973. Investigation Timeline Beginning in late 1991 and continuing for approximately five years, the Department of the Army, as DoD executive agent for chemical and biological matters, received and responded to several Congressional inquiries on behalf of three possible Project SHAD veterans. In 1992, the Army confirmed the existence of the Project SHAD program and provided, in relation to these specific inquiries, vessels involved, test locations and substances used. In a 1994 response, unclassified or redacted documents were also provided. In 1997 and 1998, there was renewed Congressional, Department of Veterans Affairs and media interest in release of additional information on the testing program. In August 2000, VA Acting Secretary Gober asked DoD to provide information concerning the Project SHAD tests. At the time of the request, information on three tests - Autumn Gold, Copper Head and Shady Grove - was needed to satisfy pending claims, but additional Project SHAD tests were believed to have occurred. In September 2000, responsibility for the investigation was assigned to the organization now known as the Deployment Health Supportate (DHSD). Weekly meetings between the DoD investigative team leader and VA's compensation and health benefits managers ensured that the DoD team was searching for the specific information that the VA needed. That information included the dates and locations of the tests, the vessels involved, lists of the chemical and biological agents, simulants, tracer materials and decontaminants documented to have been used in the tests and rosters of the personnel aboard the vessels. Investigators received some initial documentation from the Dugway Proving Ground technical library and, once the investigation expanded beyond the first three tests, searched for more in the archives of the Dahlgren Naval Surface Warfare Center. The first major hurdle was the discovery that 'SHAD,' while a valid umbrella term, was not commonly used at the time of the testing and thus was not a helpful search term. Investigators had to identify individual test names and numbers and use those as search criteria. Even with that information, document searches proved to be more difficult than expected because some of the tests had more than one name and/or test number. When the investigation was expanded beyond the first three tests, DoD decided veterans of individual tests should not have to wait for a full report of the investigation. Investigators were instructed to prepare fact sheets for delivery to the VA and publication as soon as they had compiled and declassified the necessary information. The Autumn Gold, Copper Head and Shady Grove fact sheets were provided to the VA on September 13, 2001, and posted to the DHSD Web site, DeploymentLINK, to inform the public. The Autumn Gold and Copper Head tests both used biological simulants; Shady Grove used biological warfare agents. In a joint DoD/VA press conference on January 31, 2002, the Eager Belle I and II and Scarlet Sage fact sheets were released and were posted to the DHSD Web site to inform the public. Biological simulants were used in all three tests. The Flower Drum I and II, Fearless Johnny, Purple Sage, DTC Test 68-50, and DTC Test 69-32 fact sheets were released on May 23, 2002. The fact sheets were posted to the DHSD Web site to inform the public. The Flower Drum series and Fearless Johnny used chemical warfare nerve agents. Purple Sage was a chemical simulant test. DTC Test 68-50 used biological warfare agent and DTC Test 69-32 used biological simulants. By this point, the investigation indicated that both shipboard and land-based testing were planned by the Deseret Test Center. The DoD committed to obtaining and providing to VA all medically relevant information and names of servicemembers present during all tests known to have been planned and conducted by the Deseret Test Center from 1962-1973. Document searches had already expanded to Aberdeen Proving Ground, Maryland, Fort Leonard Wood, Missouri, and several sites in the Washington, D.C., area. Investigators developed an understanding of the role the Deseret Test Center played in the planning and execution of the tests. A major breakthrough came with the discovery of several Deseret semi-annual and annual progress reports, which allowed a better understanding of the universe of tests being investigated. In July 2002, Assistant Secretary of Defense for Health Affairs William Winkenwerder Jr., MD formed a task force committed to completing the search for documents and providing all medically relevant information to the VA by June 2003. To allow public oversight of the team's progress, a chart showing the current status of the investigation was posted to the DeploymentLINK Web site and continually updated. In late August 2002, the investigative team traveled to Dugway Proving Ground, Utah, where they located additional final test reports. The team also secured a complete set of annual planning conference reports, searched and retrieved relevant documents from paper archives, initiated actions to have fragile classified films copied to a more stabile media, and interviewed several former Deseret Test Center scientists. In October 2002, DoD published 33 fact sheets based on newly discovered material from the Dugway, Utah, trip. Personnel information was provided to the VA in advance of a series of activities to communicate with Congress and the public. Publication of the fact sheets and posting the information to the DeploymentLINK Web Site followed a series of briefings to members of Congress and state delegations, Congressional testimony, and a joint DoD/VA press briefing. Fact sheets published included: Whistle Down, Night Train, Tall Timber, West Side I, Magic Sword, Big Tom, Sun Down, Devil Hole I, High Low, Elk Hunt I, Elk Hunt II, Pine Ridge, Devil Hole II, Swamp Oak I, Green Mist, West Side II, Half Note, Dew Point, Red Cloud, Watch Dog, Rapid Tan, DTC Test 68-53, DTC Test 69-10, DTC Test 69-12, DTC Test 69-14, DTC Test 69-31, DTC Test 69-75, DTC Test 70-73, Big Jack A, Big Jack B, Yellow Leaf, Red Oak I and Pin Point. Of the 33 fact sheets, 16 detailed the use of simulants and 17 detailed the use of live chemical or biological agents in the tests. In December 2002, DoD released one additional fact sheet, Cliff Rose, and corrected a previously released fact sheet, High Low, based on information provided by several veterans. The information was provided to the VA and posted to the Web Site, DeploymentLINK, to inform the public. The investigative team intensified its search into obscure references to determine the status of the remaining tests. Final declassification of medically relevant information on eight tests in June 2003 completed the public release of information on all known planned Deseret Test Center chemical and biological operational tests from 1962 to 1973. Fact sheets for three shipboard tests included Errand Boy, Folded Arrow and DTC Test 70-C. Seven fact sheets for five land-based tests included Blue Tango, DTC Test 70-11 Phase I subtest 3, DTC Test 70-11 Phase I subtest 4, DTC Test 70-74, DTC Test 73-30, DTC Test 74-10 Phase I and DTC Test 74-10 Phase II. The fact sheets were provided to the VA and posted to the Web site. Two of the shipboard tests - Errand Boy and Folded Arrow, used biological warfare agent simulants; one test - DTC Test 70-C - monitored naturally occurring airborne particulates in a marine atmosphere to gather background data. Of the five land-based tests, two used nerve agent simulants and three used biological simulants. The team also provided updated information on two tests; Big Tom and Half Note, based on recently located information and provided detailed analyses to explain why 20 tests were presumed to have been canceled. Table 1. Released Fact Sheets New Tests Revised September 13, 2001 3 3 January 31, 2002 3 2 May 23, 2002 6 5 October 9, 2002 28 27 October 31, 2002 5 4 December 31, 2002 1 1 1 June 30, 2003 10 8 2 56 50 3 The rosters of personnel aboard participating vessels were extracted from the ships' muster rolls and deck logs archived at National Archives II in College Park, Maryland. Lists of military personnel who participated in land-based tests have been assembled from available test officers' logbooks, temporary duty orders, country clearance messages, overtime reports, letters of commendation, and similar documents. Personnel rosters for tests Autumn Gold, Copperhead and Shady Grove were provided to the VA beginning in March 2001. By release of the October 2002 fact sheets, personnel rosters were being passed prior to fact sheet publication to facilitate the VA's address acquisition process. Over 8800 records have been passed to the VA, documenting the participation of 5,842 individuals in one or more of the 50 tests. Table 2. Summary of Personnel Information Flow to the VA Date No. of Records March 2001 1535 July 2001 288 January 2002 1549 February 2002 11 May 2002 836 June 2002 126 July 2002 457 September 2002 891 October 2002 18 December 2002 433 January 2003 1275 February 2003 1 April 2003 7 June 2003 1415 Records 8,842 Individuals 5,842 No military personnel data were located for the following land-based tests: Whistle Down, Big Jack A, Big Jack B, Night Train, Sun Down, Devil Hole I, Swamp Oak I, West Side II, Pin Point, Dew Point, Red Cloud, Watch Dog, Rapid Tan, Cliff Rose, DTC Test 68-53, DTC Test 69-12, DTC Test 69-14, DTC Test 69-75, DTC Test 70-11, DTC Test 70-73, DTC Test 70-74 and DTC Test 74-10. No personnel data were reported to the VA for the shipboard test Flower Drum II because the target vessel was unmanned. No personnel data were reported to the VA for the shipboard test DTC Test 70-C because this test only collected air samples of naturally occurring airborne particulates while traveling from San Diego to Panama. No agents or simulants were released. The purpose of this investigation was to locate information concerning possible exposures to military personnel. During the course of its work, the investigative team did locate documentation substantiating the participation of approximately 350 government civilian employees and contractor personnel. In its search for medically relevant information, the investigative team has contacted and/or visited every command and government research activity known to have been affiliated with the Deseret Test Center. In general, the type of records found were technical reports on tests plans and results. Such reports were and are classified for national security reasons because information on dissemination characteristics of, and operational countermeasures to, chemical and biological agents and simulants for those agents could be used by adversaries or terrorist organizations with chemical or biological weapons program ambitions. However, without compromising national security information, the identification of agents or simulants, tracers and decontaminants used in tests can be declassified and released in fact sheets to answer questions about veterans' exposures under Project 112. Fact sheets have been published, which meet the VA's criteria for the information needed to evaluate compensation claims and health care needs. The DHSD will continue to cooperate with the VA should additional information be needed for the purposes of detailed epidemiological studies. Although we have conducted an exhaustive search for information pertinent to possible VA benefits for Project 112 veterans, we cannot agree that any degree of searching records archives of a long ago terminated program would result in complete current documentation of all aspects of the program. Nonetheless, we believe the evidence found produces an accurate total picture of the Deseret Test Center program. We know of no other investigative leads that would meaningfully supplement that picture. However, the DHSD will investigate any new information that may be presented and share any additional or changed information with the VA and the public. In DoD's investigation, no test-specific medical records or classified medical records were found. Technical reports on tests did not include personally identifiable information on health effects of exposures. The purpose of the tests was not to measure health effects; the purpose was to assess dissemination characteristics and operational countermeasures. Confirming reports from some veterans that in some tests nasal swabs and gargle samples were taken, one test report records results from nasal swab and gargle samples of several individuals, but these results did not include personal identifiers that would tie the results to specific individuals or produce information for medical records. These samples taken from individuals were to test the comparative filtering effects of different types of gas masks. In relation to other tests, several references to possible health surveillance activities and protective measures were also found in technical reports of test plans or results, matters presumably documented, to the extent they actually occurred, in members' individual medical records. We found an indication that in the 11-year history of the Deseret Test Center program there were four infections and no deaths. We found no other information connecting this notation, which might involve Deseret Test Center laboratory workers, to any particular Project 112 test or tests. We found no personally identifiable information on illnesses or medical treatments. Review of the operational test planning documents and final test report documents and discussions with several of the scientists who planned and conducted these tests have provided substantiation that whenever harmful chemical or biological warfare agents were used as test substances, personnel present were appropriately protected. Actual exposure to such agents would result in acute health effects. However, when chemical or biological simulants or tracer materials were used, there were no efforts made to protect personnel because those substances were not believed to be harmful. For the shipboard operational testing, we have reviewed the ships' deck logs and have not found any indication of acute medical problems (deaths, medical evacuations, or numerous crewmembers becoming ill) at the time of this testing or immediately afterwards. This is also the case for those land-based tests for which we have located test officers' logs. In addition, neither the final test reports nor the Deseret Test Center scientists we talked with indicated any acute medical problems arising from participation in the series of tests we reviewed. Many of the chemical simulants that were used by the Deseret Test Center continue to be used as chemical simulants today. Only one of the biological simulants - Bacillus subtillis var. niger (Bacillus globigii) - continues to be used as a biological simulant for operational testing today. The other biological simulants have been replaced with agents having a lower risk of causing acute infections in immuno-compromised individuals. The decontaminants used were recognized to have acute effects on people if proper precautions were not taken; however, these substances are still being used today. The Institute of Medicine, Medical Follow-up Agency, has been contracted to conduct a study of the current health of those sailors who were present during Shipboard Hazard and Defense (SHAD) testing and to compare their health status with sailors of the same period who were on similar ships which did not participate in operational chemical and biological testing. The results of this study should be concluded in 2005. Although the information available does not suggest a pattern of illness or disability attributable to Project 112/SHAD participation, DoD believes the information that has been found, declassified, and released will greatly assist both further assessment of the entire project, such as the IOM study, and further analysis of individual veteran's disability claims. For thousands of veterans, the VA will now be able to confirm participation in SHAD and make a determination about exposure to a particular substance of substances. If scientific evidence supports a cause and effect link between such exposure and a disabling illness, the elements needed for a disability compensation award or other veterans' benefits will all be established. The DHSD hears from Project 112 veterans almost daily. Many of those veterans have sent copies of documents that have helped the investigation. Every veteran's account has been heard and factored into the investigation. Their recollections and personal documents have been very helpful in filling in the gaps in the official record. A Commendation to Project 112 Veterans The Department of Defense wishes to acknowledge the patriotic service of all who participated in the Project 112 program. Publication of this report summarizes a significant effort on the part of many people in the Department of Defense to ensure important information has been made available to service members and the Department of Veterans Affairs. DoD understands that some Project 112/SHAD veterans feel this investigation should have been conducted and the information provided years ago, and hopes that the efforts summarized in this report are responsive to their concerns. This in-depth investigation reflects an individual and collective commitment to veterans and their families to help bring closure and to replace speculation and uncertainty with fact. What We Know Today The Deseret Test Center planned 134 operational tests in support of Project 112. Fifty were conducted and 84 canceled. Table 3 shows the distribution of land- and sea-based (SHAD) tests. Table 3. Distribution of Project 112 tests Project 112 Land-based Project SHAD Planned 134 90 44 Conducted 50 31 19 Canceled 84 59 25 Approximately half of the Project SHAD tests were conducted in the open ocean. The remaining tests were conducted in the coastal waters of California, Hawaii, Puerto Rico and the Marshall Islands. Table 4 shows the locations of the 19 completed Project SHAD tests. Table 4. Location of Project SHAD Tests Atlantic Ocean 1 Vieques, Puerto Rico 1 Pacific Ocean 13 Baker Island 1 Off Hawaiian Islands 3 Off San Diego 5 Open Ocean 4 Oahu, Hawaii 3 Entire Island 2 Pearl Harbor 1 Marshall Islands 1 Total 19 Approximately two-thirds of the Project 112 land-based tests were conducted outside the continental United States. Half of those were conducted in Alaska because the test sites could be used under both temperate and arctic conditions. Most of those conducted in the continental United States were conducted at Dugway Proving Ground, Utah. Table 5 shows the primary locations of the 31 completed land-based tests; some tests conducted a portion of their trials at other listed test sites. Table 5. Primary location of Project 112 land-based tests Alaska 11 Florida 1 Hawaii 4 Georgia 1 Maryland 1 Utah 7 Canada 1 Canada and Great Britain 1 Panama 3 Unspecified 1 Total 31 Test documentation lists 21 Navy and Army vessels as participating in one or more Project SHAD tests. These vessels are listed in Table 6. Table 6. Participating vessels USNS Silas Bent USS Berkeley USS Carbonero USS Carpenter USS George Eastman USS Fechteler USS Granville S. Hall USS Hoel USNS Samuel Phillips Lee USS Navarro USS Okanogan USS Power USS Fort Snelling USS Herbert J. Thomas USS Tioga County USS Wexford County LT2080 LT2081 LT2085 LT2086 LT2087 The fact sheets for each test identify the substances used in that particular test. Summarized below are the substances documented to have been used in one or more of the Project 112 tests along, with their known health effects. Warfare Agents Chemical Agents: Tabun (GA). Tabun is an amber, non-persistent liquid, which gives off little odor when vaporizing. The vapor is colorless. When exposed to Tabun, the first symptoms a victim will experience are a runny nose, tightness in the chest and dilation of the pupils. The victim will then encounter difficulty breathing, drooling from the mouth and nausea. Ultimately the victim will become comatose and will suffocate as a consequence of convulsive spasms. Tabun is essentially absorbed through the skin; however, vapors can also be hazardous. If a person does not receive an immediate lethal dose, death will occur after approximately 20 minutes. Those receiving a less than lethal dose who do not receive immediate medical care may suffer permanent neurological damage. There is little information available regarding the long-term human health effects of exposure to low does of tabun. [stockholm International Peace Research Institute at http://www.cbw.sipri.se/docu/cw-agents/tabun.html] Sarin (GB). Sarin is a volatile and lethal nerve agent. It can enter the body by inhalation, ingestion, through the eyes, and to a lesser extent through the skin. After exposure to a sufficient dose, symptoms may occur within minutes and include runny nose, watery eyes, difficulty breathing, dimness of vision, confusion, drowsiness, coma, and death. Very little information is available regarding long-term health effects following exposures to low levels that do not cause acute symptoms. An Institute of Medicine Committee concluded that there was insufficient evidence for or against an association between low-level sarin exposure and long-term health effects. [Centers for Disease Control at http://www.bt.cdc.gov/Agent/Nerve/Sarin/Sarin.asp] Soman (GD). Soman is a colorless liquid, which gives off an odor of rotting fruit when vaporizing. The vapor is colorless. Soman is a persistent agent that can easily remain in a particular area for a day or longer, depending on the atmospheric conditions. Symptoms associated with exposure to Soman include a runny nose, tightness in the chest and constriction of the pupils. These symptoms are followed by difficulty in breathing. Ultimately the victim will become comatose and suffocate as a consequence of convulsive spasms. There is little information available regarding the long-term human health effects of exposure to soman. [stockholm International Peace Research Institute at http://www.cbw.sipri.se/docu/cw-agents/soman.html] VX. VX nerve agent is extremely lethal. It is an oily liquid that is clear, odorless, and tasteless. Death usually occurs within 10-15 minutes after absorption of a fatal dosage. VX nerve agent is one of the most toxic substances ever synthesized. Symptoms of overexposure may occur within minutes or hours, depending upon the dose. They include: constriction of pupils, headaches, runny nose, salivation, tightness in the chest, nausea, vomiting, anxiety, difficulty in thinking, muscle twitches, tremors, and weakness. With severe exposure, symptoms progress to convulsions and respiratory failure. There is little information available regarding the long-term human health effects of low doses of VX. [Centers for Disease Control and Prevention at http://www.bt.cdc.gov/Agent/Nerve/VX/ctc0006.asp or World Health Organization, Department of Sustainable Development & Environmental Protection http://209.61.192.180/phe/factsheet5.htm] Ester of Benzilic Acid (Agent BZ) (3-quinuclidinic ester of benzilic acid). Agent BZ is a psychochemical compound designed for temporarily disabling an enemy. It is designed to cause stupor, confusion and hallucinations when inhaled or absorbed through the skin. It is a white powder and may cause eye and skin irritation. Agent BZ may also irritate the digestive and respiratory tracts, if inhaled or ingested. While some effects may last several days or weeks, long-term or late-developing health effects have not been documented and seem unlikely. [http://www.fishersci.ca/msds.nsf or http://www.fas.org/nuke/guide/russia/cbw/jptac008_194001.html] Biological Agents: Coxiella burnetii (OU). This microorganism (a rickettsial species) can cause acute and chronic infection of the lung, liver, heart valve, nervous system, and other body sites (Q fever). Complications from this infection may be serious, even life threatening, but late-developing health effects would be unlikely. [Chin J, ed., Control of Communicable Diseases in Man, American Public Health Association, Washington DC, 2000, p. 407-11; Marrie, Thomas J., in Principles and Practice of Infectious Diseases, 5th edition (vol. 2), Churchill Livingstone, Philadelphia, 2000, p. 2043-50] Francisella tularensis (TT and ZZ). Formerly identified as Pasteurella tularensis, this bacterial species can cause acute infection of the lung, bloodstream, and other body sites (tularemia), and is considered a potential biological warfare agent. While complications of the acute infection may be serious, even life threatening, long-term or late-developing health effects would be very unlikely. [Cross, J et al., in Principles and Practice of Infectious Diseases, 5th edition (vol. 2), Mandell GL, Bennett JE, Dolin R, eds., Churchill Livingstone, Philadelphia, 2000, p. 2393-2402; and Dennis DT et al., JAMA 2001;285(21):2763-73] Puccinia graminis tritici (TX). This fungal species is toxic to plants, and therefore was considered a potential biological warfare agent directed against agricultural crops. It is not ordinarily considered to have either short-term or long-term human health effects. [Zajtchuk R., ed., Textbook of Military Medicine (part 1, Medical Aspects of Chemical and Biological Warfare, 1997), Office of the Army Surgeon General, Washington DC, 1997, p. 60, 460; and web site at http://www.cbwinfo.com] Staphylococcal enterotoxin B (PG2). When inhaled, this bacterial toxin can cause fever and cough, incapacitation, and (with large doses) death, and is considered a potential biological warfare agent. When ingested, it commonly causes gastrointestinal symptoms (nausea, vomiting, and diarrhea). Some symptoms may last weeks, but long-term or late-developing health effects would be unlikely. [ulrich RG et al., in Textbook of Military Medicine (part 1, Medical Aspects of Chemical and Biological Warfare, 1997), Office of the Army Surgeon General, Washington DC, 1997, p. 621-30] Riot Control Agents: CS and CS2. Two of several chemicals commonly called " Tear Gas. " CS and CS2 are white, crystalline powders dispersed into the air as either an aerosol or powder. The chemical name for CS and CS2 is ortho-chlorobenzylidene malononitrile. Riot control agents affect the eyes, airways and skin. Exposure to CS causes burning, irritation, tearing and pain in the eyes. Airway symptoms include burning, sneezing, cough, shortness of breath and increased secretions, such as runny nose and increased salivation. High concentrations of CS or CS2 can cause blistering of the skin. With commonly used concentrations, these effects are short-term and the potential for long-term health consequences is low. [http://www.metrokc.gov/health/hazard/riotcontrol.htm#cs and Cornell University, http://msds.pdc.cornell.edu/msds/sirichl/chlfz.html ] Simulants Chemical Simulants: Bis (2-ethyl-hexyl) hydrogen phosphite. This chemical compound used as an additive in industrial lubricants can cause acute irritation of the skin, eyes, and respiratory tract. There is insufficient evidence for or against long-term health effects. [NLM TOXNET at http://toxnet.nlm.nih.gov.] Di (2-ethylhexyl) phthalate (DEHP). This chemical is commonly present in flexible plastics and therefore widespread in the environment and of some concern for the general population. While low level exposures have not been shown to cause serious health effects, acute exposure to high levels of this chemical can cause irritation of the skin, eyes, and respiratory tract. DEHP has caused cancer in some animal testing, but the relevance of this testing to cancer in humans is uncertain. [DHHS PHS ATSDR ToxFAQs, Di(2- ethylhexyl)phthalate #117-81-7, April 1993, and Toxicological Profile for Di(2-ethylhexyl)phthalate (DEHP), September 2000, both available at http://www.atsdr.cdc.gov. Also WHO International Agency for Research on Cancer (IARC) Monographs on the Evaluation of Carcinogenic Risks to Humans (vol. 77, Some Industrial Chemicals updated February 23, 2000), and NLM TOXNET, Bis(2-ethylhexyl)phthalate 117-81-7 Human Health Effects, available at http://toxnet.nlm.nih.gov] Diethyl phthalate. This chemical is commonly present in flexible plastics and cosmetics as well as in some insecticides and repellents, and therefore widespread in the environment and of some concern for the general population. While low level exposures have not been shown to cause serious human health effects, acute exposure to high levels of this chemical can cause irritation of the skin and eyes in animal testing. It is mutagenic and carcinogenic in some cell and animal testing, but these effects have not been demonstrated in humans. [DHHS PHS ATSDR ToxFAQs, Diethyl Phthalate #84-66-2, September 1996, and Toxicological Profile for Diethyl Phthalate, both available at http://www.atsdr.cdc.gov. Also NLM TOXNET, Diethyl Phthalate 84-66-2, HSDB Human Health Effects and Animal Toxicity Studies, as well as CCRIS, IRIS and other databases, all available at http://toxnet.nlm.nih.gov] Dimethyl methylphosphonate (DMMP). Dimethylmethylphosphonate is used as a flame retardant, a pre-ignition additive for gasoline, an antifoam agent, a plasticizer and stabilizer, a textile conditioner and anti-static agent, and an additive for solvents and low-temperature hydraulic fluids. It may be harmful if inhaled, swallowed or absorbed through the skin. It is a suspected carcinogen. [http://ntp-server.niehs.nih.gov/htdocs/LT-studies/tr323.html] Polymethyl methacrylate (PMMA). Polymethyl methacrylate is a clear plastic used as a shatterproof replacement for glass. It is also found in acrylic latex paints. Little is known about long-term health effects of PMMA, but methyl methacrylate (from which PMMA is made) is considered not likely to be carcinogenic to humans. [EPA, Toxicological review of methyl methacrylate (CAS No. 80-62-6), January 1998, available at http://www.epa.gov, and NLM TOXNET, methyl methracrylate, HSDB Human Health Effects, available at http://toxnet.nlm.nih.gov] Methylacetoacetate (MAA). While acute exposure to this compound has been associated with irritation of skin, eyes, respiratory tract, and digestive tract, there is little or no evidence of long-term or late-developing health effects and it is not known to cause cancer in animal testing. [NLM TOXNET, Methyl acetoacetate 105-45-3, HSDB Human Health Effects and Animal Toxicity Studies, available at http://toxnet.nlm.nih.gov] Sulfur Dioxide (SO2). This compound is a common product of combustion and an environmental air pollutant. Acute exposure to high levels of sulfur dioxide can cause burning of the nose and throat, difficulty breathing, and even obstruction of the airways. Long-term exposures have been associated with breathing difficulty and lung damage. Even low level exposures may worsen asthma. It can cause cancer in some animal species, but this has not been clearly demonstrated in humans. [DHHS PHS ATSDR ToxFAQs, Sulfur dioxide #7446-09-5, June 1999, available at http://www.atsdr.cdc.gov] Trichloropropane. This chemical is used as an industrial solvent, paint and varnish remover, and cleaning and degreasing agent. Exposure to high levels for a short time causes eye and throat irritation. [http://www.atsdr.cdc.gov/tfacts57.html http://www.osha-slc.gov/fts/chemicalsmapling/data/CH_273200.html] Trioctyl phosphate (TOF). Used as a simulant for VX nerve agent. This compound, also known as tri(2-ethylhexyl) phosphate, can irritate the eyes, skin, and respiratory tract on contact. It can cause cancer in some animal species, but this has not been demonstrated in humans. [NLM TOXNET, Trioctyl phosphate 1806-54-8 or Tris(2-ethylhexyl)phosphate 78-42-2, HSDB Human Health Effects and Animal Toxicity Studies, available at http://toxnet.nlm.nih.gov] Biological Simulants: Bacillus globigii (BG). Now considered to be a variety or close relative of Bacillus subtilis, this bacterial species was used as a simulant and considered harmless to healthy individuals. Bacillus subtilis and similar Bacillus species are common in the environment, and are uncommon causes of disease. They have been associated with acute infections of the ear, meninges (brain lining), urinary tract, lung, heart valve, bloodstream, and other body sites, but always or nearly always in individuals whose health has already been compromised. Long-term or late developing health effects would be very unlikely. [Tuazon CU in Principles and Practice of Infectious Diseases, 5th edition (vol. 2), ed., Mandell GL, Bennett JE, Dolin R, Churchill Livingstone, Philadelphia, 2000, p. 2220-6, and US Environmental Protection Agency, Bacillus subtilis Final Risk Assessment, February 1997, available at http://www.epa.gov] Escherichia coli (E. coli). This bacterial species is a common inhabitant of the digestive tract but can also cause acute infection, especially when it gains access to other body sites, like the urinary tract, lung, and bloodstream. Long-term or late-developing health effects of E. coli infection would be unlikely. [Eisenstein, Barry I.et al, in Principles and Practice of Infectious Diseases, 5th edition (vol. 2), Churchill Livingstone, Philadelphia, 2000, p. 2299-301.] Serratia marcescens (SM). This bacterial species can cause acute infections of the urinary tract, lung, bloodstream, and other body sites. These infections commonly occur in individuals whose health has already been compromised, and often in patients who are already hospitalized. Long-term or late-developing health effects would be very unlikely. Its use as a bacterial marker for studying the dissemination of bacterial aerosols was discontinued in 1969. [Eisenstein, BI et al., in Principles and Practice of Infectious Diseases (chap. 206), 2000] T-3 coliphage. Coliphages are viruses (bacteriophages) that infect E. coli bacteria and would not be expected to have harmful effects on humans. [http://www.epa.gov/nerlcwww/1601ap01.pdf] Other Substances Tracer Materials: Calcofluor (fluorescent brightener 28). Used as a fluorescent tracer with Bacillus globigii. This chemical has been used as a medical laboratory stain and as a whitening agent in detergents. It can cause eye irritation in animal testing, but there is limited evidence for or against human health effects. [NLM TOXNET, Cellufluor 4193-55-9, available at net.nlm.nih.gov, and MSDS available at http://hazard.com] Phosphorous 32. One of the highest-energy beta-emitting radionucleotides commonly used in biomedical research. In general Phosphorous 32 does not pose a severe threat from ingestion or inhalation. High-energy betas from Phosphorous 32 pose an external (skin and lens of the eye) dose hazard as well as a potential internal hazard. Radiogenic health effects (primarily cancer) are observed in humans only in doses in excess of 10 rem delivered at high dose rates. Below this dose, estimation of adverse health effects is speculative. Exposure can contribute to development of cancer. [http://www.uos.harvard.edu/ehs/radsafety/gui_p32.shtml] Tiara. A luminescent gelatinous material. No other information is available. Uranine. This chemical compound is added to cosmetics for color and is commonly used (injected or applied) for medical diagnostic purposes (e.g., for vascular imaging and eye staining). It can cause acute skin reactions and acute allergic reactions (including life-threatening anaphylaxis) in some individuals. Long-term and late-developing health effects would be very unlikely. [NLM TOXNET, Fluorescein Sodium 518-47-8 and Fluorescein 2321-07-5, available at http://toxnet.nlm.nih.gov] Zinc cadmium sulfide (ZCdS). This compound was aerosolized as a tracer material for the dispersion of biological warfare agents because it had similar properties. There has been little scientific study on the toxicity of this compound when inhaled. A National Research Council (NRC) committee focused on the cadmium component as potentially most toxic. While higher concentrations and more prolonged exposures to cadmium are associated with the development of lung cancer, the concentrations and duration of exposure in the Army's tests were substantially lower. The NRC committee concluded that the risk of adverse health effects to populations in the area was low. [National Research Council (National Academies), Toxicologic Assessment of the Army's Zinc Cadmium Sulfide Dispersion] Decontaminants: Betapropiolactone (b-Propiolactone). This chemical is a disinfectant. Modern uses for b-propiolactone include vaccines, enzymes, tissue grafts, and surgical instruments; to sterilize blood plasma, water, milk, and nutrient broth; and as a vapor-phase disinfectant in enclosed spaces. Its sporicidal action kills vegetative bacteria, pathogenic fungi, and viruses. The primary routes of potential human exposure to b-propiolactone are inhalation, ingestion, and dermal contact. Acute contact can cause skin, eye, and respiratory tract irritation, sometimes with permanent damage. An International Agency for Research on Cancer (IARC) working group reported no data are available to evaluate the carcinogenicity of b-propiolactone in humans. It is carcinogenic and mutagenic in animal and bacterial cell testing. [Department of Health and Human Services, National Institutes of Health web site at http-server.niehs.nih.gov; EPA Technology Transfer network Air Toxics Website, at http://epa.gov, and NLM TOXNET, at http://toxnet.nlm.nih.gov] Calcium hypochlorite. Uses for calcium hypochlorite include bleach, cleaning solutions, and disinfectants for drinking water, wastewater purification systems, and swimming pools. When released into the air, it is broken down by sunlight and compounds commonly found in the air. Ingestion of small amounts can cause gastrointestinal irritation. Larger amounts can cause corrosive injuries to the mouth, throat, esophagus, and stomach and can be life threatening. Inhalation of chlorine gas may cause nasal irritation, sore throat, and coughing. Contact with the skin may cause burning pain, inflammation, and blisters. The International Agency for Research on Cancer (IARC) has determined that hypochlorite salts are not classifiable as to their carcinogenicity in humans. [ATSDR Medical management guidelines for calcium hypochlorite and sodium hypochlorite, available at http://www.atsdr.cdc.gov] Monoethanolamine. This chemical causes eye and skin burns, may be harmful or fatal if swallowed, may cause dizziness and drowsiness, and causes respiratory tract irritation and possibly damage. Chronic exposure to skin may cause a persistent irritation or dermatitis. Repeated inhalation may cause lung damage. [http://www.astrochemicals.com/10129.pdf] Other: Aedes aegypti mosquitoes. Aedes aegypti mosquitoes used in this test were not infected. Health effects at the time would be the usual swelling and irritation associated with mosquito bites. No long-term or latent effects would be expected. / First Page / Last Page / Next Page / Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.